Predict your next investment

HEALTHCARE | Medical Devices & Equipment / Patient Monitoring
cardiomems.com

See what CB Insights has to offer

Total Raised

$204.89M

Investors Count

17

Deal Terms

7

CardioMems Funding, CardioMems Valuation & CardioMems Revenue

10 Fundings

CardioMems's latest funding round was a Acquired for on June 2, 2014.

CardioMems's valuation in December 2007 was $180.53M.

CardioMems's latest post-money valuation is from June 2014.

Sign up for a free 30-day trial to see CardioMems's valuations in June 2014 and more.

Date

Round

Amount

Investors

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Revenue

Sources

6/2/2014

Acquired

$99M

$0.00B

((9.99x))

FY 1234

1

9/17/2010

Corporate Minority

$60M

$0.00B

((9.99x))

FY 1234

1

5/19/2010

Series G

$37.9M

$0.00B

((9.99x))

FY 1234

8/24/2009

Series F

$99M

$0.00B

((9.99x))

FY 1234

10

12/20/2007

Series E

$99M

$180.53M

$0.00B

((9.99x))

FY 1234

10

Date

6/2/2014

9/17/2010

5/19/2010

8/24/2009

12/20/2007

Round

Acquired

Corporate Minority

Series G

Series F

Series E

Amount

$60M

$37.9M

$99M

$99M

Investors

Valuation

$99M

$180.53M

Revenue

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

$0.00B

((9.99x))

FY 1234

Sources

1

1

10

10

CardioMems Deal Terms

7 Deal Terms

CardioMems's deal structure is available for 7 funding rounds, including their Acquired from June 02, 2014.

Round

Acquired

Corporate Minority

Series G

Series F

Series E

Funding Date

$99M

$99M

$99M

$99M

$99M

Pre-Money Valuation

$99M

$99M

$99M

Post-Money Valuation

$99M

$99M

$99M

Amount Raised

$99M

$99M

$99M

$99M

$99M

Shares Authorized

Issuance Price

$99M

$99M

$99M

$99M

Dividend Rate

$99M

$99M

$99M

$99M

Liquidation Preferences

$99M

$99M

$99M

$99M

Liquidation Price

Participation

$99M

$99M

$99M

Conversion Price

Anti Dilution

$99M

$99M

$99M

$99M

General Voting

$99M

$99M

$99M

$99M

$99M

Board Voting

$99M

$99M

$99M

$99M

$99M

Par Value

Round

Funding Date

Pre-Money Valuation

Post-Money Valuation

Amount Raised

Shares Authorized

Issuance Price

Dividend Rate

Liquidation Preferences

Liquidation Price

Participation

Conversion Price

Anti Dilution

General Voting

Board Voting

Par Value

Acquired

$99M

$99M

$99M

$99M

$99M

$99M

Corporate Minority

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series G

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series F

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

Series E

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

$99M

CardioMems Investors

17 Investors

CardioMems has 17 investors. St. Jude Medical invested in CardioMems's Acquired funding round.

First funding

Last Funding

Investor

Rounds

Board Seats

Type

Location

8/24/2009

6/2/2014

4
Series F, Series G (2010), Corporate Minority (2010), Acquired (2014)

Corporation

Minnesota

11/14/2003

5/19/2010

6
Series F, Series B (2003), Series C (2005), Series D (2006), Series E (2007), Series G (2010)

Robert Mashal

Private Equity

Massachusetts

11/14/2003

5/19/2010

6
Series F, Series B (2003), Series C (2005), Series D (2006), Series E (2007), Series G (2010)

Lee Wrubel

Venture Capital

Massachusetts

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Corporation

Minnesota

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Venture Capital

Michigan

First funding

8/24/2009

11/14/2003

11/14/2003

00/00/0000

00/00/0000

Last Funding

6/2/2014

5/19/2010

5/19/2010

00/00/0000

00/00/0000

Investor

Subscribe to see more

Subscribe to see more

Rounds

4
Series F, Series G (2010), Corporate Minority (2010), Acquired (2014)
6
Series F, Series B (2003), Series C (2005), Series D (2006), Series E (2007), Series G (2010)
6
Series F, Series B (2003), Series C (2005), Series D (2006), Series E (2007), Series G (2010)

Subscribe to see more

Subscribe to see more

Board Seats

Robert Mashal

Lee Wrubel

Subscribe to see more

Subscribe to see more

Type

Corporation

Private Equity

Venture Capital

Corporation

Venture Capital

Location

Minnesota

Massachusetts

Massachusetts

Minnesota

Michigan

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.